This webcast will discuss the clinical approach to a child with short stature, the importance of endocrine investigations for early diagnosis, and the social and psychological impacts of short stature in the Asia Pacific region. The experts will address appropriate management of a child with short stature and thalassaemia, looking specifically at nutritional status, and present strategies for optimal GH management and treatment of the range of growth disorders.
| Topics | Speaker |
|---|---|
| Introduction and diagnostic approach to short stature | Martin Savage |
| Heightism and the psychological burden of short stature | Han-Wook Yoo |
| Nutritional status in the assessment of short stature | Yazid Jalaludin |
| GH treatment of idiopathic short stature in a multi-centre national study | Han-Wook Yoo |
| Management of children with short stature and thalassaemia | Yazid Jalaludin |
| Factors influencing the response to growth hormone therapy | Martin Savage |
| Discussion and Q & A | All |
| Summary and close | Martin Savage |
This webcast is suitable for, but not limited to, clinical paediatric endocrinologists, clinical adult endocrinologists, paediatric endocrine nurses, and all other healthcare professionals interested in the management of growth disorders.
Following this webcast you will be able to:
- Debate the appropriate diagnosis and assessment of short stature, including the impact of nutritional status
- Apply strategies for optimal management of the different short stature disorders, taking into account comorbidities and factors influencing response to growth hormone
- Assess the social and psychological impact of short stature in the context of emerging economies
Emeritus Professor of Paediatric Endocrinology
William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, London, UK
Martin Savage is Emeritus Professor of Paediatric Endocrinology at William Harvey Research Institute, Barts and the London School of Medicine & Dentistry in London. He was head of the Paediatric Endocrine Unit at Barts and the London School of Medicine from 1982 to 2007. He is a clinician with clinical and research interests in growth disorders, specifically those with abnormalities in the growth hormone-IGF-1 axis. His main research field has been the phenotype:genotype relationships of GH-IGF-1 axis defects. He published the first human case of an IGF-1 gene defect in the New England Journal of Medicine in 1996.
His other clinical interests are Cushing’s syndrome and growth in chronic inflammatory diseases. He was General Secretary of the European Society for Paediatric Endocrinology (ESPE) from 1997 to 2004. Professor Savage has lectured in 59 countries world-wide and has published over 440 original articles, reviews, textbook chapters and books. In 2007, he was awarded the ESPE Andrea Prader Prize for contributions to paediatric endocrinology and in 2018 he received a Visionary Award from the American Human Growth Foundation. He continues to lecture nationally and internationally.
Disclosures
- Consultancy agreements with Ipsen, Sandoz, Merck KGaA, Darmstadt, OPKO, Genexine-Handok
- Honoraria for lectures from GeneScience, Novo Nordisk
Professor of Pediatric Endocrinology, Metabolism and Genetics
Asan Medical Center Children’s Hospital, Seoul, South Korea
Han-Wook Yoo received his MD from the College of Medicine, Seoul National University in 1979, where he completed his clinical training as an intern and resident, followed by a clinical fellowship in pediatrics at Seoul National University Children’s Hospital in 1986. He furthered his clinical and research training with a postdoctoral fellowship at Mount Sinai Medical Center, New York, USA, and in 1992 he was certified as a clinical molecular geneticist by the American Board of Medical Genetics. In 1994, he joined the faculty of University of Ulsan College of Medicine, Asan Medical Center, in Seoul. In 2001, he became Chairman of the department of pediatrics. From 2009 until 2012, he served as the President of Asan Medical Center Children’s Hospital.
Professor Yoo has published more than 250 peer-reviewed articles. He has received several awards for his research and he is an active member of many international academic societies in the field of endocrinology and medical genetics. His main interests are focused on the characterization of molecular & functional defects of endocrine genetic disorders.
Disclosures
- No conflicts of interest to disclose.
Associate Professor of Pediatrics
University of Malaya, Kuala Lumpur, Malaysia
Muhammad Yazid Jalaludin is currently Head of Department of Paediatrics and Associate Professor, Faculty of Medicine, University of Malaya. He is also a Consultant Paediatrician and Consultant Paediatric Endocrinologist at the University Malaya Medical Centre (UMMC). He completed his fellowship in Pediatric Endocrinology and Diabetes at Children’s Hospital of Philadelphia, USA, after obtaining his MBBS and Masters in Paediatrics, both from University of Malaya.
He is currently the President of the Malaysian Paediatric Association (MPA 2017-2019) and the Asia Pacific Paediatric Endocrine Society (APPES 2018-2020). He is also a member of The Endocrine Society USA, International Society for Paediatric and Adolescent Diabetes (ISPAD) and Malaysian Endocrine and Metabolic Society (MEMS).
Dr Jalaludin’s main research interest is in growth (nutrition), obesity and type 2 diabetes mellitus, and vitamin D in children. He is one of the Principal Investigators (Clinical) for [email protected], co-PI for MyHeARTs and co-investigator in projects Co-PoWR and DEWI. He holds many national and international research grants and acts as Scientific Advisor for many multicentre international researches for type 2 diabetes in children. His work has been published in various academic journals and as textbook chapters.
Disclosures
- No conflicts of interest to disclose.
This programme is made possible thanks to an educational grant received from: Merck Healthcare KGaA, Darmstadt, Germany.
